Background: Epitestosterone is prohibited by sport authorities because its administration will lower the urinary testosterone/epitestosterone ratio, a marker of testosterone administration. A definitive method for detecting epitestosterone administration is needed. Methods: We developed a gas chromatography-combustion-isotope ratio mass spectrometry method for measuring the ␦ 13 C values for urinary epitestosterone. Sample preparation included deconjugation with ␤-glucuronidase, solid-phase extraction, and semipreparative HPLC. Epitestosterone concentrations were determined by gas chromatography-mass spectrometry for urines obtained from a control group of 456 healthy males. Epitestosterone ␦ 13 C values were determined for 43 control urines with epitestosterone concentrations >40 g/L (139 nmol/L) and 10 athletes' urines with epitestosterone concentrations >180 g/L (624 nmol/L), respectively. Results: The log epitestosterone concentration distribution was gaussian [mean, 3.30; SD, 0.706; geometric mean, 27.0 g/L (93.6 nmol/L)]. The ␦ 13 C values for four synthetic epitestosterones were low (less than or equal to ؊30.3‰) and differed significantly (P <0.0001). The SDs of between-assay precision studies were low (<0.73‰). The mean ␦ 13 C values for urine samples obtained from 43 healthy males was ؊23.8‰ (SD, 0.93‰). Nine of 10 athletes' urine samples with epitestosterone concentrations >180 g/L (624 nmol/L) had ␦ 13 C values within ؎ 3 SD of the control group. The ␦ 13 C value of epitestosterone in one sample was ؊32.6‰ (z-score, 9.4), suggesting that epitestosterone was administered. In addition, the likelihood of simultaneous testosterone administration was supported by low ␦ 13 C values for androsterone and etiocholanolone.
Epitestosterone (E), the 17␣ epimer of testosterone, is a naturally occurring steroid found in urine in concentrations similar to those of testosterone. Although epitestosterone was first isolated from human urine in 1964 (1 ), a physiologic role for epitestosterone has not been established. In humans it is produced in the testes (2 ) and probably by the ovaries (3 ) and adrenals (4 ) , but it has minimal or no androgenic activity (5 ) . Epitestosterone is not available as a pharmaceutical agent, but it can be purchased in bulk from chemical companies.
Epitestosterone is of great interest in the field of doping control because it is the denominator in the testosterone/ epitestosterone (T/E) 3 ratio, an indirect marker of testosterone (T) administration. When testosterone is administered, the excretion rate of urinary testosterone increases, the excretion rate of epitestosterone declines (6 ) , and the T/E ratio increases. An increased T/E ratio is also an indirect marker of androstenedione and dehydroepiandrosterone administration (7, 8 ) . If the T/E ratio exceeds 6, doping control laboratories report the case to the sport authorities, who conduct an investigation of the cause of the increased T/E ratio (9 ) .
One technique for circumventing the T/E test is to self-administer epitestosterone (10 ) . Athletes who administer testosterone and therefore have an increased T/E ratio have been reported to administer epitestosterone to rapidly lower the T/E ratio. To thwart this activity, the International Olympic Committee (IOC) classifies epitestosterone as a urine-manipulating agent, and laboratories Drug Monitoring and Toxicology are required to report cases if the urine epitestosterone concentration exceeds 200 g/L (693 nmol/L). However, unless the urine epitestosterone is exceedingly increased [Ͼ1000 g/L (3467 nmol/L)], it has been difficult to prove in an administrative hearing that epitestosterone has been administered. In part this is attributable to the wide range in concentrations of urinary steroids (11 ) .
It has now been convincingly established that the deviation, in parts per thousand, in 13 C content between an unknown and an international standard (␦ 13 C), calculated as {[( 13 C/ 12 C) sample Ϫ ( 13 C/ 12 C) standard]/( 13 C/ 12 C) standard} ϫ 1000, where 13 C/ 12 C refers to the isotope ratio in the sample or an international standard, for pharmaceutical testosterone is low compared with endogenous testosterone and that administration of pharmaceutical testosterone lowers the ␦ 13 C value of urinary metabolites of testosterone (12) (13) (14) (15) . We therefore investigated the carbon isotope ratio of chemical epitestosterones and determined the ␦ 13 C value of urinary epitestosterone in urine samples obtained from healthy controls and athletes. In addition, we describe the distribution of urine epitestosterone values in a large population of healthy males.
Materials and Methods chemicals
HPLC-grade methanol was purchased from Fisher Chemicals, acetonitrile from Pierce Chemical Company, and cyclohexane from Fluka. Bakerbond C 18 , 500-mg solidphase extraction columns were obtained from JT Baker and used on a 24-port vacuum manifold from Burdick and Jackson. ␤-Glucuronidase from Escherichia coli was supplied by Boehringer Mannheim. Chemical-grade epitestosterone was obtained from four of the six different US vendors: Sigma (lot 100H4021), Research Plus, Inc. (lot 09891), Steraloids, Inc (lot L951), and Alltech, Inc. (lot 163).
individuals providing urine for epitestosterone concentrations
Urines were collected from 456 male, first-year UCLA medical students between the ages of 20 and 38 from six consecutive classes (years 1996 -2001), who were enrolled in a laboratory course in biological chemistry. The experiment was conducted under the oversight of the Human Subjects Protection Committee. The students had the option to give a medical and drug history and to declare their ethnicity. No student declared taking steroids or reported any chronic disease. The ethnicity choices were Caucasian, Asian, black, Hispanic, and other. The students collected 24-h urine samples beginning with the first voided morning urine. All urines were stored at 4°C during collection and at Ϫ4°C until analysis. The pH was measured to the nearest half-unit with a dipstick, the specific gravity to the nearest thousandth with a refractometer, and the creatinine by HPLC (16 ) . Two of the 24-h volumes were Ͻ500 mL, probably because one or more urinations were missed. However, the pH, specific grav-ity, and analytical data gave no reason to question the authenticity of the urines; thus, none were excluded. None of the urines in the study was found to contain exogenous androgens.
students and athletes providing urine for epitestosterone ␦ 13 C values
The controls were a subset of the group described above and included 43 medical students between the ages of 21 and 31 from the 1999 -2001 school years. The urines were selected because they contained Ն40 g/L (Ն139 nmol/L) epitestosterone. In addition, 10 urine samples from the athlete testing program that our laboratory conducts for various sport agencies were analyzed. These samples were selected because their epitestosterone concentrations were at least 180 g/L (624 nmol/L) and they were available at the time of the study.
sample preparation and gas chromatographicmass spectrometric analysis for determination of urine steroid concentrations
The concentrations of testosterone, epitestosterone, and other endogenous steroids were estimated from a urine steroid screen (13 ) . Sample preparation included centrifugation if solids were present, the addition of [16, 16, H 3 ]testosterone to 2.5 mL of urine to give a concentration of 40 g/L (139 nmol/L), solid-phase extraction (Bond-Elut 57-m C 18 cartridge; 3 mL/500 mg; Varian Associates), enzymatic hydrolysis with 50 L of ␤-glucuronidase from E. coli (Roche Diagnostics; lot 1585665; Ͼ200 kU/L at 37°C), and extraction with diethyl ether. After evaporation of the solvent, the trimethylsilyl ethers and enol ethers of the compounds of interest were prepared by reconstituting in 50 L of MSTFA-NH 4 I-dithioerythritol (1000 L:1.8 mg:4.5 mg) and incubating at 60°C for 20 min. The gas chromatographic-mass spectrometric analysis was conducted with Hewlett-Packard gas chromatography-mass spectrometry (GC/MS) systems in the selected-ion monitoring mode as described previously (13, 17 ) . This analysis quantifies free steroids and glucuronides together. The T/E ratio was determined from the peak height ratio of testosterone/epitestosterone (m/z 432). The screen includes positive and negative quality-control (QC) samples whose estimated T/E ratios must fall within tolerance ranges and are monitored on QC charts. The concentration of epitestosterone was calculated from the peak height of m/z 435 of [16, 16, H 3 ]testosterone (T ph 435) and the peak height of m/z 432 of epitestosterone (E ph 432) by the following formula: epitestosterone concentration ϭ (E ph 432) (40 g/L)/(T ph 435). The overall recovery of epitestosterone in this method exceeds 90% (18 ) . Two QC urines containing testosterone at 10 and 100 g/L, analyzed 150 times over 2 weeks, gave CVs of 10% and 13%, respectively. Steroid sulfates were not targeted.
sample preparation for epitestosterone gas chromatography-combustion-isotope ratio mass spectrometry (gc/c/irms) analysis
To 5 mL of urine we added 1.0 mL of 0.2 mol/L phosphate buffer (pH 7.0) and 100 L of ␤-glucuronidase from E. coli. Following incubation for 1 h at 60°C, the hydrolysate was poured into a solid-phase extraction column (Bakerbond C 18 Octadecyl; 500 mg; 6 mL; Mallinckrodt Baker) conditioned with 6 mL of methanol followed by 6 mL of water, washed with 6 mL of water, and eluted with 6 mL of acetonitrile. The eluate containing the free steroids was dried under a nitrogen stream (Turbo Vap LV evaporator; Zymark), redissolved in 200 L of acetonitrile, and injected on a semipreparative C 18 column (Sphereclone ODS2; 250 ϫ 10 mm; 5-m bead size; Phenomenex). The acetonitrile-water (46:54 by volume) mobile phase was delivered by a HP 1090 liquid chromatograph at a flow rate of 3.8 mL/min. The eluate was monitored at 240 nm. The epitestosterone fraction was collected at the retention time observed for a calibrator (Ϯ 1 min; typically 19.5-21.5 min), evaporated to dryness, reconstituted in 30 L of cyclohexane, and transferred to an autosampler vial. Nineteen of the samples (35%) were analyzed by GC/MS to check the identity and purity of the epitestosterone.
gc/c/irms analysis
The GC/C/IRMS analysis was performed on a Finnigan Delta Plus isotope ratio mass spectrometer connected to a HP Model 6890 gas chromatograph via a Finnigan Combustion III interface. The GC column, inlet, and oven temperatures were the same as for the above GC/MS system. The IRMS conditions have been described (13 ) . In addition, we measured the ␦ 13 C values for acetylated androsterone and etiocholanolone as described previously (13 ) . qc and precision QC and precision studies were performed on two urine samples, designated negative QC (Neg-QC) and positive QC (Pos-QC). The epitestosterone concentration (free plus glucuronide) in the Neg-QC was 130 g/L (451 nmol/L). The Pos-QC was prepared by extracting the steroids on a XAD-2 column from a 2-L pool of female urine and adding epitestosterone (Sigma; lot 18F-4057; ␦ 13 C ϭ Ϫ34.0‰). The QC urines were prepared and stored in 5-mL aliquots at Ϫ20°C until analysis. The within-assay precision of the method was determined by preparing three aliquots each of Pos-QC and Neg-QC and injecting each once. The between-assay precision of the method was determined by extracting one aliquot of Pos-QC and Neg-QC per day for 4 days and injecting each once.
statistics
The normality of the distributions was assessed with the Anderson-Darling (A 2 ) test, and the distributions were compared using the general linear model with the Duncan multiple range test (19 ) . The ␦ 13 C values for the chemical-grade epitestosterones were compared using the general linear model. The log-power transformation (20 ) was applied to the concentrations of urine epitestosterone per milligram of creatinine.
Results

control group urine epitestosterone concentrations
The percentile distributions of epitestosterone concentrations are shown in Table 1 . Of the 456 members of the control group, 36.4% were Caucasian, 21.7% were Asian, 19.3% were Hispanic, and 7.5% were black. Of the remaining 15% (n ϭ 69), 46 gave their ethnicity as "other", and 23 did not declare any ethnicity. These two groups were combined and listed as "unidentified" in Table 1 . Table 1 also shows the percentile distribution of ng epitestosterone/mg creatinine (ng-E/mg-cr) for all individuals. The distribution of urinary epitestosterone was not gaussian (Fig. 1, top 
gc/ms identification and gc/c/irms analysis of urinary epitestosterone
Shown in Fig. 2A is a HPLC chromatogram of a representative urine extract; the GC/MS total-ion chromatogram of the corresponding HPLC fraction is shown in Fig. 2B . Urinary epitestosterone was identified by matching retention time (Ϯ 2%) and mass spectrum (ion ratios, Ϯ 20%) with those of a calibrator. The chromatogram shows a symmetrical peak and no evidence of coeluting compounds. Fig. 2C shows the GC/C/IRMS chromatogram of the HPLC fraction. The carbon dioxide peak corresponding to the combusted epitestosterone peak eluted at 1101 s. Its shape was symmetric with no tailing.
␦ 13 C values for synthetic epitestosterone
As shown in Table 2 , the ␦ 13 C values obtained for epitestosterone from four different chemical suppliers ranged from Ϫ30.3‰ to Ϫ34.9‰. The epitestosterone ␦ 13 C value was higher for the compound obtained from vendor A than for those obtained from the other three suppliers (P Ͻ0.0001). There were no significant differences in the ␦ 13 C values for epitestosterone from vendors B, C, and D (P Ͼ0.08). 
qc and precision
The descriptive statistics for the within-and betweenassay precision experiment using Neg-QC and Pos-QC are shown in Table 3 . The within-assay SDs for Neg-QC and Pos-QC were Ϯ 0.44‰ (CV ϭ 1.9%) and Ϯ 0.46‰ (CV ϭ 1.4%), respectively. The between-assay SDs for Neg-QC and Pos-QC were Ϯ 0.73‰ (CV ϭ 3.3%) and Ϯ 0.52‰ (CV ϭ 1.6%), respectively. For the within-and between-assay precision, the mean ␦ 13 C values for epitestosterone in the Neg-QC were Ϫ22.9‰ and Ϫ22.2‰, respectively. For the Pos-QC, the corresponding values were Ϫ33.6‰ and Ϫ33.7‰, respectively.
control group ␦ 13 C values and epitestosterone concentrations
In the urines obtained from the 43 healthy students with epitestosterone concentrations Ն40 g/L (139 nmol/L), the mean ␦ 13 C value of epitestosterone for all was Ϫ23.8‰ (range, Ϫ21.8‰ to Ϫ25.6‰; SD, 0.93; Table 4 ), and these data were normally distributed (A 2 ϭ 0.42; P ϭ 0.25). In addition, Table 4 shows the means, SDs, and CVs for the students as a function of their declared ethnicity. The mean ␦ 13 C values for the four ethnic groups ranged from Ϫ23.2‰ (blacks) to Ϫ24.2‰ (Caucasian) and did not differ significantly (P ϭ 0.27). The range of epitestosterone concentrations was 43-138 g/L (149 -478 nmol/L; zscores, 0.7-2.3). The median urinary T/E ratio was 0.58 (range, 0.06 -2.04).
␦ 13 C values in athletes' urines with high epitestosterone concentrations
Shown in Table 5 are summaries of the epitestosterone and testosterone concentrations, T/E ratios, and ␦ 13 C values for urines from the 10 male athletes with urinary epitestosterone concentrations Ͼ180 g/L (Ͼ624 nmol/ L). The median concentration of epitestosterone in these urines was 249 g/L (863 nmol/L) [range, 180-1176 g/L (624 -4077 nmol/L)]. The median testosterone concentration and T/E ratio were 71 g/L (range, 8 -1183 g/L) and 0.30 (range, 0.04 -1.11), respectively. Except for ath-lete 10, the epitestosterone ␦ 13 C values were similar to those of the control group and within the range of Ϯ 3 SD (Ϫ26.6‰ to Ϫ21.0‰). The epitestosterone ␦ 13 C value for athlete urine 10 was very low (Ϫ32.6‰) and 9.4 z-score units below the mean of the control group.
␦ 13 C values for acetylated androsterone and etiocholanolone from athletes' urines with high epitestosterone concentrations
The urinary androsterone and etiocholanolone ␦ 13 C values for the athletes were measured to determine the likelihood that testosterone or a related steroid was administered (13 ) . Table 5 shows the ␦ 13 C values for 7 of these 10 samples. There was insufficient volume to perform the IRMS analysis on the other three urines. Except for athlete 10, the ␦ 13 C values for acetylated etiocholanolone (range, Ϫ20.7‰ to Ϫ23.3‰) and androsterone (range, Ϫ20.2‰ to Ϫ21.9‰) were within the reference interval (13 ) . For athlete 10, the ␦ 13 C values for etiocholanolone acetate (Ϫ30.7‰) and androsterone acetate (Ϫ31.4‰) were in the range found in testosterone users (13 ) .
Discussion
The quality of GC/C/IRMS measurements depends first on chromatographic peak purity. In this assay, the epitestosterone peak was separated from all other peaks, and its shape was symmetric. Peak purity was achieved by optimizing an extraction method that included semipreparative HPLC fractionation, and peak purity was checked by GC/MS analysis. The within-and betweenassay imprecision of the two QC samples was very low (CV Ͻ4%) and in excellent agreement with imprecision data for our diol and androsterone/etiocholanolone IRMS studies (12, 13 ) . All samples tested produced a sufficient IRMS response with only 5 mL of urine; thus, the method is suitable for doping control where a limited volume of urine is available. It takes ϳ2 days to process one batch of samples, but the turnaround time can be shortened to one 18-h day. Most IRMS assays for steroids determine the ␦ 13 C value of derivatized steroids (12) (13) (14) (15) 21 ) . In this assay, we were able to obtain the ␦ 13 C values on underivatized epitestosterone. Derivatization was not necessary to improve peak symmetry and resolution. The ␦ 13 C values for samples of epitestosterone obtained from four different chemical companies ranged from Ϫ30.3‰ to Ϫ34.9‰. These values were similar to those in previous reports on synthetic steroids (14, (21) (22) (23) . It is possible that the epitestosterone obtained from vendors B, C, and D came from a common source. The mean epitestosterone ␦ 13 C value for the control group of 43 students was Ϫ23.8‰ (SD, 0.93‰), which is similar to the value reported (Ϫ23.3‰) for underivatized urinary testosterone (22 ) . The low SD yields a relatively narrow Ϯ 3 SD range (Ϫ21.0‰ to Ϫ26.6‰). In sport drug testing, it is typical to require a positive case to be at least ϩ3 SD from the mean. Thus, in testing for potential epitestosterone administration, the critical value is the difference between the control group mean Ϫ3 SD and the ␦ 13 C values for the epitestosterone administered. This difference, which ranges from 3.7‰ to 8.3‰, is relatively large, indicating that the assay will be useful for detecting doping with epitestosterone.
The optimal approach for establishing the clinical validity of an epitestosterone detection scheme is to administer epitestosterone to healthy volunteers and analyze urine samples collected at various times. Because epitestosterone is not available in the US as an approved pharmaceutical, it is not possible to perform such a study unless an investigational new drug permit is obtained from the Food and Drug Administration. Currently, obtaining an investigational new drug permit is not an option. We therefore determined the ␦ 13 C values for epitestosterone in urine samples obtained from selected athletes. These samples come to us for routine sport testing, and we have no information on the histories of the athletes who provide them. Because the steroid screening analysis estimates the concentration of epitestosterone, we selected samples for IRMS analysis that had high epitestosterone concentrations.
The concentration of epitestosterone in the urine of athlete 10 [1176 g/L (4077 nmol/L)] is the highest we have encountered in the latest 45 000 samples from athletes tested. In addition, the epitestosterone ␦ 13 C value of Ϫ32.6‰, the lowest observed in this study, is 9.4 z-score units above the mean of the control group. These data strongly suggest that athlete 10 recently administered synthetic epitestosterone. If an athlete takes synthetic testosterone or a steroid that is metabolized to androsterone and etiocholanolone, the ␦ 13 C values for androsterone and etiocholanolone acetate are Ϫ30.0‰ or lower (13 ) ; thus the values in Table 4 (Ϫ31.4‰ and Ϫ30.7‰) strongly suggest that athlete 10 was also taking testosterone. Only 2% of administered epitestosterone is recovered in urine as androsterone and etiocholanolone (4 ) . Thus, the low ␦ 13 C values are not likely to be attributable to metabolism of epitestosterone to androsterone and etiocholanolone. In addition, this athlete's T/E ratio (1.1) was the same as the median of 3710 male athletes (9 ); thus, his very high epitestosterone (1176 g/L) was balanced by an equally high testosterone (1183 g/L), which is a additional indication that he was taking testosterone. There is no evidence that testosterone is metabolized to epitestosterone (6, 24 ) ; thus it is most unlikely that the epitestosterone ␦ 13 C values are influenced by testosterone administration.
The epitestosterone concentrations in the urine of the remaining nine athletes (athletes 1-9 in Table 5 ) were all Ͼ180 g/L (624 nmol/L), but for eight of the nine, the epitestosterone ␦ 13 C value z-scores were negative. In other words, the values were greater than the mean of the control group. Athlete 6 was suspicious for exogenous epitestosterone use because his epitestosterone concentration was 251 g/L (870 nmol/L) and his ␦ 13 C value was Ϫ26.1‰. The latter, however, was within Ϯ 3 SD (Ϫ21.0‰ to Ϫ26.6‰) of the control group mean. Thus, the only evidence that any of the other athletes (athletes 1-5 and 7-9) used epitestosterone is the high concentration of epitestosterone. This indicates that the IOC epitestosterone cutoff flags samples that might not represent epitestosterone abuse. Use of an epitestosterone/creatinine cutoff might offer an improvement. The IOC requires laboratories to report cases with epitestosterone Ͼ200 g/L (693 nmol/L) so that further investigation may be conducted. This situation is satisfactory provided that sanctions are not automatically taken in cases in which the epitestosterone concentration is Ͼ200 g/L (693 nmol/L) and no ␦ 13 C value is available.
There are no other publications on the detection of epitestosterone administration by determining epitestosterone ␦ 13 C values. In a study involving one participant who received 50 mg of epitestosterone, the ␦ 13 C value of a diol metabolite (measured as the diacetate) of epitestosterone was highly negative (15 ) . In addition, after the administration of testosterone enanthate to cattle, the ␦ 13 C value of diacetates of urine epitestosterone fell from approximately Ϫ25‰ to Ϫ30‰ and remained low for more than 16 days (unlike humans, cattle metabolize testosterone to epitestosterone) (25 ) . The time course of urinary epitestosterone ␦ 13 C values after epitestosterone administration in humans has not been reported.
This IRMS method for determining the ␦ 13 C values for urinary epitestosterone was developed to provide much needed additional support for the detection of doping with epitestosterone. Epitestosterone has no clinical use (other than to lower the urine T/E ratio) and is not available as a pharmaceutical; therefore, a urine sample with an epitestosterone concentration Ͼ200 g/L (693 nmol/L) and a ␦ 13 C value lower than Ϫ26.6‰ (control group mean Ϫ 3 SD) provides convincing evidence of epitestosterone doping. Such cases are likely to also have low ␦ 13 C values for urinary testosterone metabolites, which reflect doping with testosterone or another steroid that is metabolized to testosterone. In addition, we have provided a detailed description of the distribution of urine epitestosterone concentrations in healthy controls, which is useful for interpreting high concentrations of urinary epitestosterone.
